Top

Current HIV/AIDS Reports

Published in:

25-05-2023 | Human Immunodeficiency Virus

Interventions to Reduce Alcohol Use and HIV Risk among Sexual and Gender Minority Populations: a Systematic Review

Authors: Carolyn Lauckner, Kimberly Haney, Fidelis Sesenu, Trace Kershaw

Published in: Current HIV/AIDS Reports | Issue 4/2023

Abstract

Purpose of Review

Sexual and gender minority (SGM) individuals are diagnosed with HIV at disproportionate rates, and hazardous alcohol use can increase their HIV risk. This review assessed the state of the literature examining interventions for addressing alcohol use and sexual HIV risk behaviors among SGM individuals.

Recent Findings

Fourteen manuscripts from 2012 to 2022 tested interventions that address both alcohol use and HIV risk behaviors among SGM populations, with only 7 randomized controlled trials (RCTs). Virtually all the interventions targeted men who have sex with men, with none focused on transgender populations or cisgender women. While they demonstrated some evidence of effectiveness in reducing alcohol use and/or sexual risk, the outcomes varied widely between studies.

Summary

More research is needed that tests interventions in this area, particularly for transgender individuals. The use of larger-scale RCTs with diverse populations and standardized outcome measures are needed to strengthen the evidence base.

Boyd CJ, Veliz PT, Stephenson R, Hughes TL, Mccabe SE. Severity of alcohol, tobacco, and drug use disorders among sexual minority individuals and their “not sure” counterparts. LGBT Health. 2019;6(1):15–22. https://doi.org/10.1089/lgbt.2018.0122.CrossRefPubMedPubMedCentral

Kelly J, Davis C, Schlesinger C. Substance use by same sex attracted young people: prevalence, perceptions and homophobia. Drug Alcohol Rev. 2015;34(4):358–65. https://doi.org/10.1111/dar.12158.CrossRefPubMed

Williams EC, Frost MC, Rubinsky AD, Glass JE, Wheat CL, Edmonds AT, et al. Patterns of alcohol use among transgender patients receiving care at the Veterans Health Administration: overall and relative to nontransgender patients. J Stud Alcohol Drugs. 2021;82(1):132–41. https://doi.org/10.15288/jsad.2021.82.132.CrossRefPubMedPubMedCentral

Tupler LA, Zapp D, Dejong W, Ali M, O’Rourke S, Looney J, et al. Alcohol-related blackouts, negative alcohol-related consequences, and motivations for drinking reported by newly matriculating transgender college students. Alcohol Clin Exp Res. 2017;41(5):1012–23. https://doi.org/10.1111/acer.13358.CrossRefPubMedPubMedCentral

Gonzalez CA, Gallego JD, Bockting WO. Demographic characteristics, components of sexuality and gender, and minority stress and their associations to excessive alcohol, cannabis, and illicit (noncannabis) drug use among a large sample of transgender people in the United States. J Prim Prev. 2017;38(4):419–45. https://doi.org/10.1007/s10935-017-0469-4.CrossRefPubMedPubMedCentral

Connolly D, Gilchrist G. Prevalence and correlates of substance use among transgender adults: a systematic review. Addict Behav. 2020;111:106544. https://doi.org/10.1016/j.addbeh.2020.106544.CrossRefPubMed

Kcomt L, Evans-Polce RJ, Boyd CJ, Mccabe SE. Association of transphobic discrimination and alcohol misuse among transgender adults: results from the U.S. Transgender Survey. Drug Alcohol Depend. 2020;215:108223. https://doi.org/10.1016/j.drugalcdep.2020.108223.CrossRefPubMedPubMedCentral

Gower AL, Rider GN, Brown C, Mcmorris BJ, Coleman E, Taliaferro LA, et al. Supporting transgender and gender diverse youth: protection against emotional distress and substance use. Am J Prev Med. 2018;55(6):787–94. https://doi.org/10.1016/j.amepre.2018.06.030.CrossRefPubMedPubMedCentral

Kalb N, Roy Gillis J, Goldstein AL. Drinking to cope with sexual minority stressors: understanding alcohol use and consequences among LGBQ emerging adults. J Gay Lesbian Ment Health. 2018;22(4):310–26.CrossRef

10.

Slater ME, Godette D, Huang B, Ruan WJ, Kerridge BT. Sexual orientation-based discrimination, excessive alcohol use, and substance use disorders among sexual minority adults. LGBT Health. 2017;4(5):337–44. https://doi.org/10.1089/lgbt.2016.0117.CrossRefPubMedPubMedCentral

11.

Delgado JR, Segura ER, Lake JE, Sanchez J, Lama JR, Clark JL. Event-level analysis of alcohol consumption and condom use in partnership contexts among men who have sex with men and transgender women in Lima, Peru. Drug Alcohol Depend. 2017;170:17–24. https://doi.org/10.1016/j.drugalcdep.2016.10.033.CrossRefPubMed

12.

Newcomb ME. Moderating effect of age on the association between alcohol use and sexual risk in MSM: evidence for elevated risk among younger MSM. AIDS Behav. 2013;17(5):1746–54. https://doi.org/10.1007/s10461-013-0470-8.CrossRefPubMedPubMedCentral

13.

Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410. https://doi.org/10.1007/s10461-011-0131-8.CrossRefPubMed

14.

Operario D, Nemoto T, Iwamoto M, Moore T. Unprotected sexual behavior and HIV risk in the context of primary partnerships for transgender women. AIDS Behav. 2011;15(3):674–82. https://doi.org/10.1007/s10461-010-9795-8.CrossRefPubMedPubMedCentral

15.

Centers for Disease Control and Prevention: HIV by Group. https://www.cdc.gov/hiv/group/index.html (2019). Accessed 11 Oct 2021.

16.

Sander PM, Cole SR, Stall RD, Jacobson LP, Eron JJ, Napravnik S, et al. Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS. 2013;27(5):815–23. https://doi.org/10.1097/qad.0b013e32835cff4b.CrossRefPubMed

17.

Baliunas D, Rehm J, Irving H, Shuper P. Alcohol consumption and risk of incident human immunodeficiency virus infection: a meta-analysis. Int J Public Health. 2010;55(3):159–66. https://doi.org/10.1007/s00038-009-0095-x.CrossRefPubMed

18.

Rehm J, Shield KD, Joharchi N, Shuper PA. Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studies. Addiction. 2012;107(1):51–9. https://doi.org/10.1111/j.1360-0443.2011.03621.x.CrossRefPubMed

19.

Scott-Sheldon LA, Carey KB, Cunningham K, Johnson BT, Carey MP, Team MR. Alcohol use predicts sexual decision-making: a systematic review and meta-analysis of the experimental literature. AIDS Behav. 2016;20(1):19–39.CrossRefPubMedCentral

20.

Kalichman SC, Eaton L. Alcohol-antiretroviral interactive toxicity beliefs as a potential barrier to HIV pre-exposure prophylaxis among men who have sex with men. J Int AIDS Soc. 2017;20(1):21534. https://doi.org/10.7448/ias.20.1.21534.CrossRefPubMedPubMedCentral

21.

Storholm ED, Volk JE, Marcus JL, Silverberg MJ, Satre DD. Risk perception, sexual behaviors, and PrEP adherence among substance-using men who have sex with men: a qualitative study. Prev Sci. 2017;18(6):737–47. https://doi.org/10.1007/s11121-017-0799-8.CrossRefPubMedPubMedCentral

22.

Oldfield BJ, Edelman EJ. Addressing unhealthy alcohol use and the HIV pre-exposure prophylaxis care continuum in primary care: a scoping review. AIDS Behav. 2021;25(6):1777–89. https://doi.org/10.1007/s10461-020-03107-6.CrossRefPubMed

23.

Shuper PA, Joharchi N, Bogoch II, Loutfy M, Crouzat F, El-Helou P, et al. Alcohol consumption, substance use, and depression in relation to HIV Pre-Exposure Prophylaxis (PrEP) nonadherence among gay, bisexual, and other men-who-have-sex-with-men. BMC Public Health. 2020;20(1):1782. https://doi.org/10.1186/s12889-020-09883-z.

24.

Midanik LT, Tam TW, Weisner C. Concurrent and simultaneous drug and alcohol use: results of the 2000 National Alcohol Survey. Drug Alcohol Depend. 2007;90(1):72–80. https://doi.org/10.1016/j.drugalcdep.2007.02.024.CrossRefPubMedPubMedCentral

25.

Egan KL, Cox MJ, Suerken CK, Reboussin BA, Song EY, Wagoner KG, et al. More drugs, more problems? Simultaneous use of alcohol and marijuana at parties among youth and young adults. Drug Alcohol Depend. 2019;202:69–75. https://doi.org/10.1016/j.drugalcdep.2019.07.003.CrossRefPubMedPubMedCentral

26.

Gleason N, Smith G, Canning JR, George WH, Larimer ME, Jennings TL, et al. The relationship between alcohol and drug use, compulsive sexual behavior, and condomless anal sex in men who have sex with men: analysis of retrospectively-reported sexual behavior. AIDS Behav. 2023. https://doi.org/10.1007/s10461-022-03961-6.CrossRefPubMed

27.

Kidd JD, Paschen-Wolff MM, Mericle AA, Caceres BA, Drabble LA, Hughes TL. A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations. J Subst Abuse Treat. 2022;133:108539.CrossRefPubMed

28.

Dimova ED, Elliott L, Frankis J, Drabble L, Wiencierz S, Emslie C. Alcohol interventions for LGBTQ+ adults: a systematic review. Drug Alcohol Rev. 2022;41(1):43–53.CrossRefPubMed

29.

Wray TB, Grin B, Dorfman L, Glynn TR, Kahler CW, Marshall BD, et al. Systematic review of interventions to reduce problematic alcohol use in men who have sex with men. Drug Alcohol Rev. 2016;35(2):148–57.CrossRefPubMed

30.

Herbst JH, Beeker C, Mathew A, McNally T, Passin WF, Kay LS, et al. The effectiveness of individual-, group-, and community-level HIV behavioral risk-reduction interventions for adult men who have sex with men: a systematic review. Am J Prev Med. 2007;32(4):38–67.CrossRef

31.

Herbst JH, Sherba RT, Crepaz N, DeLuca JB, Zohrabyan L, Stall RD, et al. A meta-analytic review of HIV behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005;39(2):228–41.PubMed

32.

Garofalo R, Kuhns LM, Reisner SL, Mimiaga MJ. Behavioral interventions to prevent HIV transmission and acquisition for transgender women: a critical review. J Acquir Immune Defic Syndr. 2016;72(Suppl 3):S220.CrossRefPubMedPubMedCentral

33.

Maulsby C, Millett G, Lindsey K, Kelley R, Johnson K, Montoya D, et al. A systematic review of HIV interventions for black men who have sex with men (MSM). BMC Public Health. 2013;13:1–13.CrossRef

34.••

Kahler CW, Pantalone DW, Mastroleo NR, Liu T, Bove G, Ramratnam B, et al. Motivational interviewing with personalized feedback to reduce alcohol use in HIV-infected men who have sex with men: a randomized controlled trial. J Consult Clin Psychol. 2018;86(8):645. This randomized controlled trial addressing alcohol use among HIV-positive MSM had significant effects on both alcohol use and sexual risk behaviors.CrossRefPubMedPubMedCentral

35.

Liu Y, Vermund SH, Ruan Y, Liu H, Rivet Amico K, Simoni JM, et al. Peer counselling versus standard-of-care on reducing high-risk behaviours among newly diagnosed HIV-positive men who have sex with men in Beijing, China: a randomized intervention study. J Int AIDS Soc. 2018;21(2):e25079.CrossRefPubMedPubMedCentral

36.

Santos G-M, Coffin PO, Vittinghoff E, DeMicco E, Das M, Matheson T, et al. Substance use and drinking outcomes in Personalized Cognitive Counseling randomized trial for episodic substance-using men who have sex with men. Drug Alcohol Depend. 2014;138:234–9.CrossRefPubMedPubMedCentral

37.••

Wray TB, Kahler CW, Simpanen EM, Operario D. A preliminary randomized controlled trial of game plan, a web application to help men who have sex with men reduce their HIV risk and alcohol use. AIDS Behav. 2019;23:1668–79. This innovative trial specifically targeted alcohol and HIV risk behaviors and led to significant improvements in both areas.CrossRefPubMedPubMedCentral

38.

Kurtz SP, Stall RD, Buttram ME, Surratt HL, Chen M. A randomized trial of a behavioral intervention for high risk substance-using MSM. AIDS Behav. 2013;17:2914–26.CrossRefPubMed

39.••

Pachankis JE, Hatzenbuehler ML, Rendina HJ, Safren SA, Parsons JT. LGB-affirmative cognitive-behavioral therapy for young adult gay and bisexual men: a randomized controlled trial of a transdiagnostic minority stress approach. J Consult Clin Psychol. 2015;83(5):875. This randomized controlled trial with young adult sexual minority cisgender men had significant effects on both alcohol use and sexual risk behaviors.CrossRefPubMedPubMedCentral

40.••

Santos G-M, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, et al. Feasibility, acceptability and tolerability of targeted naltrexone for non-dependent methamphetamine-using and binge-drinking men who have sex with men. J Acquir Immune Defic Syndr. 2016;72(1):21. This randomized controlled trial represents the only reviewed study that utilized medications for substance use disorder and found significant effects on both alcohol use and sexual risk behaviors.CrossRefPubMedPubMedCentral

41.

Chavez K, Palfai TP. Feasibility of a mobile messaging-enhanced brief intervention for high risk heavy drinking MSM: a pre-pilot study. Alcohol Treat Q. 2020;38(1):87–105.CrossRefPubMed

42.

Carrico AW, Flentje A, Gruber VA, Woods WJ, Discepola MV, Dilworth SE, et al. Community-based harm reduction substance abuse treatment with methamphetamine—using men who have sex with men. J Urban Health. 2014;91:555–67.CrossRefPubMedPubMedCentral

43.

Williams PP, Carney T, Parry CD. Reducing substance use and sexual risk behaviour among men who have sex with men in South Africa. S Afr J Sci. 2016;112(9–10):1–5.

44.

Reback CJ, Fletcher JB. Outcomes from a homegrown HIV prevention program for extremely high-risk, substance-using men who have sex with men with multiple health disparities. J Gay Lesbian Soc Serv. 2017;29(2):167–81.CrossRefPubMedPubMedCentral

45.

Smith NG, Hart TA, Kidwai A, Vernon JR, Blais M, Adam B. Results of a pilot study to ameliorate psychological and behavioral outcomes of minority stress among young gay and bisexual men. Behav Ther. 2017;48(5):664–77.CrossRefPubMed

46.

Hart TA, Noor SW, Vernon JR, Antony MM, Gardner S, O’Cleirigh C. Integrated cognitive-behavioral therapy for social anxiety and HIV/STI prevention for gay and bisexual men: a pilot intervention trial. Behav Ther. 2020;51(3):503–17.CrossRefPubMed

47.

Lelutiu-Weinberger C, Pachankis JE, Gamarel KE, Surace A, Golub SA, Parsons JT. Feasibility, acceptability, and preliminary efficacy of a live-chat social media intervention to reduce HIV risk among young men who have sex with men. AIDS Behav. 2015;19:1214–27.CrossRefPubMedPubMedCentral

48.

Centers for Disease Control and Prevention: HIV and transgender people: HIV prevalence. https://www.cdc.gov/hiv/group/gender/transgender/hiv-prevalence.html (2022). Accessed 9 Mar 2023.

49.

Stutterheim SE, van Dijk M, Wang H, Jonas KJ. The worldwide burden of HIV in transgender individuals: an updated systematic review and meta-analysis. PLOS ONE. 2021;16(12):e0260063. https://doi.org/10.1371/journal.pone.0260063.CrossRefPubMedPubMedCentral

50.

Shokoohi M, Kinitz DJ, Pinto D, Andrade-Romo Z, Zeng Z, Abramovich A, et al. Disparities in alcohol use and heavy episodic drinking among bisexual people: a systematic review, meta-analysis, and meta-regression. Drug Alcohol Depend. 2022;235:109433. https://doi.org/10.1016/j.drugalcdep.2022.109433.CrossRefPubMed

51.

Centers for Disease Control and Prevention: HIV and women: HIV diagnoses. https://www.cdc.gov/hiv/group/gender/transgender/hiv-prevalence.html (2022). Accessed 9 Mar 2023.

52.

Centers for Disease Control and Prevention: HIV and African American people: HIV diagnoses. https://www.cdc.gov/hiv/group/racialethnic/africanamericans/diagnoses.html (2023). Accessed 9 Mar 2023.

53.

Centers for Disease Control and Prevention: HIV and Hispanic/Latino people: HIV diagnoses. https://www.cdc.gov/hiv/group/racialethnic/hispanic-latino/diagnoses.html (2022). Accessed 9 Mar 2023.

Title: Interventions to Reduce Alcohol Use and HIV Risk among Sexual and Gender Minority Populations: a Systematic Review
Authors: Carolyn Lauckner
Kimberly Haney
Fidelis Sesenu
Trace Kershaw
Publication date: 25-05-2023
Publisher: Springer US
Keyword: Human Immunodeficiency Virus
Published in: Current HIV/AIDS Reports / Issue 4/2023
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI: https://doi.org/10.1007/s11904-023-00660-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2023

Interventions to Improve Adolescent HIV Care Outcomes

Update on the Impact of Depot Medroxyprogesterone Acetate on Vaginal Mucosal Endpoints and Relevance to Sexually Transmitted Infections

Spiraling Risk: Visualizing the multilevel factors that socially pattern HIV risk among gay, bisexual & other men who have sex with men using Complex Systems Theory

A Review of Serious Gaming as an Intervention for HIV Prevention

Mpox and HIV: a Narrative Review

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage